Timolol Maleate

26921-17-5 Categories: ,
  • # LGM Pharma is a Timolol Maleate CAS# 26921-17-5 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, samples, sourcing, purity and more.
  • # Questions? Call our customer API support number 1-(800)-881-8210.
  • # LGM Pharma offers this active ingredient but not the finished dosage forms.
  • Inquire about this product >>

Product Details:

  • Product Name: Timolol Maleate
  • CAS #: 26921-17-5
  • IUPAC: (S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1, 2, 5-thiadiazol-3-yl)oxy]propan-2-ol
  • ATC: C07AA06
  • PubChem: 5478
  • DrugBank: APRD00229
  • Formula: C13-H24-N4-O3-S.C4-H4-O4
  • Molecular Mass: 432.495
  • Synonyms: (-)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)-2-propanol maleate, (-)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)-2-propanol maleate (1:1) (salt), (S)-Timolol hydrogen maleate, Betime, Blocadren, CCRIS 1057, EINECS 248-111-5, Istalol, l-Timolol maleate, MK 950, Timacor, Timolol hydrogen maleate, Timolol maleate, Timoptic, Timoptic in Ocudose, Timoptic-XE, UNII-P8Y54F701R
  • SMILES: c1(c(OC[C@H](CNC(C)(C)C)O)nsn1)N1CCOCC1.OC(C=C/C(O)=O)=O
  • InChl: 1S/C13H24N4O3S.C4H4O4/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17;5-3(6)1-2-4(7)8/h10,14,18H,4-9H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t10-;/m0./s1
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants


  • Technical packages as well as access to filed DMF,
    ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any
    submission type based on specific customer requirements
This website uses cookies. By using our site, you agree to our terms of service